MedWatch

Drug Safety: It’s About More Than Just Compliance

2 Comments / Epilepsy, Multiple Sclerosis, Organ Transplants / By

Engaging in social media presents a number of uncertainties to pharmaceutical companies. In a world where much of the medical dialog has moved online, these uncertainties have emerged due to absent or unclear guidelines from the Federal Drug Administration (FDA), privacy and regulatory concerns about engaging directly with patients, and the potential for significant consequences. […]

Drug Safety: It’s About More Than Just Compliance Read More »

PatientsLikeMe Offers Adverse Event Reporting for MS Patients

4 Comments / Multiple Sclerosis, Patient Experiences / By

PatientsLikeMe is proud to announce a pilot program in our multiple sclerosis community which helps patients submit treatment-related adverse events directly to the The U.S. Food and Drug Administration (FDA) through our site. “Adverse events” are severe side effects or events that occur as a result of using a medication, medical product or device.  Understanding

PatientsLikeMe Offers Adverse Event Reporting for MS Patients Read More »

Scroll to Top